Skip to main content
WallStreetDigest.

Search

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Coherus Oncology (CHRS)

$1.01 $0.00 (0.00%)

Day’s range
$0.9800–$1.02
Volume
686,791

CHRS price history

CHRS closed at $1.01 on Oct. 26, 2026. Over the past year, its daily close ranged from $0.9587 on Oct. 19, 2026 to $2.51 on Jan. 27, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $0.5000 to $3.00, not from zero.
Data table: CHRS daily closes, the past year
CHRS daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$1.01
Oct. 23, 2026$1.01
Oct. 22, 2026$1.05
Oct. 21, 2026$1.02
Oct. 20, 2026$1.00
Oct. 19, 2026$0.9587
Oct. 16, 2026$0.9900
Oct. 15, 2026$1.07
Oct. 14, 2026$1.05
Oct. 13, 2026$1.07
Oct. 12, 2026$1.03
Oct. 9, 2026$1.07
Oct. 8, 2026$1.07
Oct. 7, 2026$1.01
Oct. 6, 2026$1.03
Oct. 5, 2026$1.12
Oct. 2, 2026$1.16
Oct. 1, 2026$1.16
Sept. 30, 2026$1.21
Sept. 29, 2026$1.18
Sept. 28, 2026$1.14
Sept. 25, 2026$1.13
Sept. 24, 2026$1.17
Sept. 23, 2026$1.26
Sept. 22, 2026$1.30
Sept. 21, 2026$1.37
Sept. 18, 2026$1.35
Sept. 17, 2026$1.23
Sept. 16, 2026$1.22
Sept. 15, 2026$1.33
Sept. 14, 2026$1.43
Sept. 11, 2026$1.33
Sept. 10, 2026$1.34
Sept. 9, 2026$1.32
Sept. 8, 2026$1.37
Sept. 4, 2026$1.42
Sept. 3, 2026$1.37
Sept. 2, 2026$1.42
Sept. 1, 2026$1.37
Aug. 31, 2026$1.35
Aug. 28, 2026$1.41
Aug. 27, 2026$1.46
Aug. 26, 2026$1.45
Aug. 25, 2026$1.37
Aug. 24, 2026$1.36
Aug. 21, 2026$1.42
Aug. 20, 2026$1.32
Aug. 19, 2026$1.33
Aug. 18, 2026$1.34
Aug. 17, 2026$1.15
Aug. 14, 2026$1.20
Aug. 13, 2026$1.14
Aug. 12, 2026$1.17
Aug. 11, 2026$1.21
Aug. 10, 2026$1.24
Aug. 7, 2026$1.27
Aug. 6, 2026$1.26
Aug. 5, 2026$1.45
Aug. 4, 2026$1.48
Aug. 3, 2026$1.44
July 31, 2026$1.41
July 30, 2026$1.47
July 29, 2026$1.41
July 28, 2026$1.44
July 27, 2026$1.46
July 24, 2026$1.41
July 23, 2026$1.43
July 22, 2026$1.43
July 21, 2026$1.47
July 20, 2026$1.42
July 17, 2026$1.40
July 16, 2026$1.39
July 15, 2026$1.44
July 14, 2026$1.45
July 13, 2026$1.47
July 10, 2026$1.54
July 9, 2026$1.63
July 8, 2026$1.65
July 7, 2026$1.67
July 6, 2026$1.56
July 2, 2026$1.45
July 1, 2026$1.44
June 30, 2026$1.40
June 29, 2026$1.45
June 26, 2026$1.50
June 25, 2026$1.48
June 24, 2026$1.52
June 23, 2026$1.46
June 22, 2026$1.48
June 18, 2026$1.48
June 17, 2026$1.39
June 16, 2026$1.38
June 15, 2026$1.36
June 12, 2026$1.40
June 11, 2026$1.42
June 10, 2026$1.36
June 9, 2026$1.42
June 8, 2026$1.42
June 5, 2026$1.45
June 4, 2026$1.58
June 3, 2026$1.47
June 2, 2026$1.52
June 1, 2026$1.57
May 29, 2026$1.59
May 28, 2026$1.65
May 27, 2026$1.66
May 26, 2026$1.64
May 22, 2026$1.61
May 21, 2026$1.57
May 20, 2026$1.51
May 19, 2026$1.48
May 18, 2026$1.49
May 15, 2026$1.57
May 14, 2026$1.63
May 13, 2026$1.71
May 12, 2026$1.71
May 11, 2026$1.95
May 8, 2026$1.75
May 7, 2026$1.76
May 6, 2026$1.75
May 5, 2026$1.79
May 4, 2026$1.73
May 1, 2026$1.80
April 30, 2026$1.78
April 29, 2026$1.74
April 28, 2026$1.77
April 27, 2026$1.84
April 24, 2026$1.75
April 23, 2026$1.76
April 22, 2026$1.80
April 21, 2026$1.82
April 20, 2026$1.99
April 17, 2026$1.98
April 16, 2026$1.90
April 15, 2026$1.88
April 14, 2026$1.80
April 13, 2026$1.71
April 10, 2026$1.68
April 9, 2026$1.65
April 8, 2026$1.70
April 7, 2026$1.67
April 6, 2026$1.67
April 2, 2026$1.73
April 1, 2026$1.74
March 31, 2026$1.69
March 30, 2026$1.60
March 27, 2026$1.63
March 26, 2026$1.66
March 25, 2026$1.77
March 24, 2026$1.71
March 23, 2026$1.64
March 20, 2026$1.52
March 19, 2026$1.61
March 18, 2026$1.58
March 17, 2026$1.68
March 16, 2026$1.66
March 13, 2026$1.63
March 12, 2026$1.69
March 11, 2026$1.78
March 10, 2026$1.95
March 9, 2026$1.93
March 6, 2026$1.82
March 5, 2026$1.76
March 4, 2026$1.76
March 3, 2026$1.65
March 2, 2026$1.65
Feb. 27, 2026$1.67
Feb. 26, 2026$1.69
Feb. 25, 2026$1.68
Feb. 24, 2026$1.67
Feb. 23, 2026$1.62
Feb. 20, 2026$1.63
Feb. 19, 2026$1.71
Feb. 18, 2026$1.63
Feb. 17, 2026$1.61
Feb. 13, 2026$1.61
Feb. 12, 2026$2.01
Feb. 11, 2026$2.04
Feb. 10, 2026$2.11
Feb. 9, 2026$2.06
Feb. 6, 2026$2.14
Feb. 5, 2026$2.09
Feb. 4, 2026$2.22
Feb. 3, 2026$2.22
Feb. 2, 2026$2.17
Jan. 30, 2026$2.16
Jan. 29, 2026$2.33
Jan. 28, 2026$2.22
Jan. 27, 2026$2.51
Jan. 26, 2026$2.28
Jan. 23, 2026$2.06
Jan. 22, 2026$1.59
Jan. 21, 2026$1.64
Jan. 20, 2026$1.55
Jan. 16, 2026$1.60
Jan. 15, 2026$1.66
Jan. 14, 2026$1.60
Jan. 13, 2026$1.70
Jan. 12, 2026$1.65
Jan. 9, 2026$1.69
Jan. 8, 2026$1.53
Jan. 7, 2026$1.43
Jan. 6, 2026$1.36
Jan. 5, 2026$1.44
Jan. 2, 2026$1.37
Dec. 31, 2025$1.42
Dec. 30, 2025$1.41
Dec. 29, 2025$1.34
Dec. 26, 2025$1.33
Dec. 24, 2025$1.34
Dec. 23, 2025$1.32
Dec. 22, 2025$1.40
Dec. 19, 2025$1.36
Dec. 18, 2025$1.36
Dec. 17, 2025$1.35
Dec. 16, 2025$1.39
Dec. 15, 2025$1.39
Dec. 12, 2025$1.35
Dec. 11, 2025$1.43
Dec. 10, 2025$1.33
Dec. 9, 2025$1.29
Dec. 8, 2025$1.28
Dec. 5, 2025$1.20
Dec. 4, 2025$1.23
Dec. 3, 2025$1.22
Dec. 2, 2025$1.16
Dec. 1, 2025$1.27
Nov. 28, 2025$1.36
Nov. 26, 2025$1.31
Nov. 25, 2025$1.28
Nov. 24, 2025$1.28
Nov. 21, 2025$1.16
Nov. 20, 2025$1.10
Nov. 19, 2025$1.16
Nov. 18, 2025$1.21
Nov. 17, 2025$1.13
Nov. 14, 2025$1.19
Nov. 13, 2025$1.26
Nov. 12, 2025$1.36
Nov. 11, 2025$1.35
Nov. 10, 2025$1.26
Nov. 7, 2025$1.34
Nov. 6, 2025$1.49
Nov. 5, 2025$1.57
Nov. 4, 2025$1.55
Nov. 3, 2025$1.60
Oct. 31, 2025$1.68
Oct. 30, 2025$1.70
Oct. 29, 2025$1.73
Oct. 28, 2025$1.74
Oct. 27, 2025$1.60

Key figures

52-week range
$0.9587–$2.51Low Oct. 19, 2026; high Jan. 27, 2026
Average daily volume
1.3MPast 3 months
Market value
$156.0M
Dividend yield
—
From 52-week high
−59.76%

Price change

1 month
−10.62%
3 months
−28.37%
Year to date
−28.87%
1 year
−38.79%

$1,000 a year ago

$1,000 put into CHRS at the close on Oct. 24, 2025 would be worth $612.

Price only, dividends not included.

What Wall Street says about CHRS

In the past 90 days, Wall Street firms published 1 rating or price-target action on CHRS: 1 lowered price target.

Rating and price-target actions on CHRS, past 90 days
ActionRating
GuggenheimCuts targetBuy$12 to $10

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Coherus Oncology, Inc. Common Stock

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Headquarters
Redwood City, Calif.
Employees
144
Listed
Nov. 6, 2014
Sector
Health care
Industry
Biological products, (no diagnostic substances)

coherus.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about CHRS is on the site yet.

  • AMGNAmgen Inc
  • GILDGilead Sciences Inc
  • MRNAModerna, Inc. Common Stock
  • RVMDRevolution Medicines, Inc. Common Stock
  • BIIBBiogen Inc. Common Stock
  • EXELExelixis Inc